Paiva, Tadeu Ferreira <br/><br/>
Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.  [electronic resource] 

 -  BMC cancer  Sep 2015 
 - 643 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-015-1648-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lung Neoplasms--genetics<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neovascularization, Pathologic--drug therapy<br/>Receptor, Notch1--biosynthesis<br/>Vascular Endothelial Growth Factor Receptor-1--biosynthesis<br/>Vascular Endothelial Growth Factor Receptor-3--biosynthesis